PURPOSE: The debridement, antibiotic and implant retention (DAIR) procedure is an option for patients with prosthetic hip joint infections for whom arthroplasty removal is problematic. Unfortunately, some of the guidelines proposed for deciding on DAIR management of arthroplasty infections fail to take into consideration the role of the infecting pathogen. While Staphylococcus aureus and streptococci are major contributors to infected hip arthroplasties, their respective contributions to treatment success or failure rates with the DAIR procedure have not been thoroughly analysed from a microbiological perspective. METHODS: This retrospective study included all patients who were hospitalised in Geneva University Hospitals between 1996 and 2012 and were initially treated with DAIR for prosthetic hip joint monomicrobial infection due to S. aureus or Streptococcus spp. The outcome of DAIR treatment was evaluated after a minimal follow-up of two years. A literature search was also performed to retrieve data from additional DAIR-treated cases in other institutions. RESULTS: In our institution, 38 DAIR-treated patients with hip arthroplasty monomicrobial infections underwent at least one surgical debridement (median two, range one to five), exchange of mobile parts and concomitant targeted antibiotic therapy for several weeks or months. A literature search identified outcome data in other institutions from 52 additional DAIR-treated cases according to our study criteria. After merging our own data with those retrieved from other reports, we found a failure rate of 21 % instead of 24 % for S. aureus-infected, DAIR-treated patients, but no failure in 14 streptococcal-infected patients. In the pooled data, the failure rate linked with S. aureus infections was significantly higher than that with Streptococcus ssp. (19/90 vs 0/14 episodes; Fisher's exact test, P = 0.07). CONCLUSIONS: DAIR-treated patients with prosthetic hip joint infections due to S. aureus tended to have worse outcomes than those infected with Streptococcus spp. The specific influence of the infecting pathogen should be considered in future guidelines and recommendations.
PURPOSE: The debridement, antibiotic and implant retention (DAIR) procedure is an option for patients with prosthetic hip joint infections for whom arthroplasty removal is problematic. Unfortunately, some of the guidelines proposed for deciding on DAIR management of arthroplasty infections fail to take into consideration the role of the infecting pathogen. While Staphylococcus aureus and streptococci are major contributors to infected hip arthroplasties, their respective contributions to treatment success or failure rates with the DAIR procedure have not been thoroughly analysed from a microbiological perspective. METHODS: This retrospective study included all patients who were hospitalised in Geneva University Hospitals between 1996 and 2012 and were initially treated with DAIR for prosthetic hip joint monomicrobial infection due to S. aureus or Streptococcus spp. The outcome of DAIR treatment was evaluated after a minimal follow-up of two years. A literature search was also performed to retrieve data from additional DAIR-treated cases in other institutions. RESULTS: In our institution, 38 DAIR-treated patients with hip arthroplasty monomicrobial infections underwent at least one surgical debridement (median two, range one to five), exchange of mobile parts and concomitant targeted antibiotic therapy for several weeks or months. A literature search identified outcome data in other institutions from 52 additional DAIR-treated cases according to our study criteria. After merging our own data with those retrieved from other reports, we found a failure rate of 21 % instead of 24 % for S. aureus-infected, DAIR-treated patients, but no failure in 14 streptococcal-infectedpatients. In the pooled data, the failure rate linked with S. aureus infections was significantly higher than that with Streptococcus ssp. (19/90 vs 0/14 episodes; Fisher's exact test, P = 0.07). CONCLUSIONS: DAIR-treated patients with prosthetic hip joint infections due to S. aureus tended to have worse outcomes than those infected with Streptococcus spp. The specific influence of the infecting pathogen should be considered in future guidelines and recommendations.
Authors: C A Aboltins; M A Page; K L Buising; A W J Jenney; J R Daffy; P F M Choong; P A Stanley Journal: Clin Microbiol Infect Date: 2007-02-28 Impact factor: 8.067
Authors: Susan M Odum; Thomas K Fehring; Adolph V Lombardi; Ben M Zmistowski; Nicholas M Brown; Jeffrey T Luna; Keith A Fehring; Erik N Hansen Journal: J Arthroplasty Date: 2011-05-31 Impact factor: 4.757
Authors: Khalid Seghrouchni; Christian van Delden; Dennis Dominguez; Mohamed Benkabouche; Louis Bernard; Mathieu Assal; Pierre Hoffmeyer; Ilker Uçkay Journal: Int Orthop Date: 2011-10-05 Impact factor: 3.075
Authors: A Soriano; S García; G Bori; M Almela; X Gallart; F Macule; J Sierra; J A Martínez; S Suso; J Mensa Journal: Clin Microbiol Infect Date: 2006-09 Impact factor: 8.067
Authors: P Sendi; B Christensson; I Uçkay; A Trampuz; Y Achermann; K Boggian; D Svensson; M Widerström; W Zimmerli Journal: J Hosp Infect Date: 2011-07-20 Impact factor: 3.926
Authors: Khalid A Azzam; Mark Seeley; Elie Ghanem; Matthew S Austin; James J Purtill; Javad Parvizi Journal: J Arthroplasty Date: 2010-04-08 Impact factor: 4.757
Authors: P Vaudaux; T Ferry; I Uçkay; P François; J Schrenzel; S Harbarth; A Renzoni Journal: Eur J Clin Microbiol Infect Dis Date: 2012-07-26 Impact factor: 3.267
Authors: Line Zürcher-Pfund; Ilker Uçkay; Laurence Legout; Axel Gamulin; Pierre Vaudaux; Robin Peter Journal: Int Orthop Date: 2013-05-22 Impact factor: 3.075
Authors: Georgios K Triantafyllopoulos; Lazaros A Poultsides; Vasileios I Sakellariou; Wei Zhang; Peter K Sculco; Yan Ma; Thomas P Sculco Journal: Int Orthop Date: 2015-03-31 Impact factor: 3.075
Authors: Christian Fölsch; Maike Federmann; Klaus D Kuehn; Clemens Kittinger; Stefan Kogler; Gernot Zarfel; Martina Kerwat; Steve Braun; Susanne Fuchs-Winkelmann; Jürgen R J Paletta; Philip P Roessler Journal: Int Orthop Date: 2014-11-08 Impact factor: 3.075
Authors: Elysia A Masters; Stephanie P Hao; H Mark Kenney; Yugo Morita; Chad A Galloway; Karen L de Mesy Bentley; Benjamin F Ricciardi; Brendan F Boyce; Edward M Schwarz; Irvin Oh Journal: J Orthop Res Date: 2020-12-29 Impact factor: 3.494
Authors: E Fiaux; M Titecat; O Robineau; J Lora-Tamayo; Y El Samad; M Etienne; N Frebourg; N Blondiaux; B Brunschweiler; F Dujardin; E Beltrand; C Loiez; V Cattoir; J P Canarelli; C Hulet; M Valette; S Nguyen; F Caron; H Migaud; E Senneville Journal: BMC Infect Dis Date: 2016-10-13 Impact factor: 3.090